Business Context and Reporting Period
Company: WiSA Technologies, Inc. (Note: Input metadata referenced "Datavault AI Inc.", but the filing text identifies the registrant as WiSA Technologies, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: December 6, 2023
Event Date: December 5, 2023
Context: The Company entered into warrant inducement agreements with holders of its Series B Convertible Preferred Stock purchase warrants to encourage exercise of existing warrants and raise capital.
Key Financial Metrics and Transaction Details
- Potential Gross Proceeds: Up to approximately $6.0 million if all existing warrants are exercised.
- Existing Warrants: Exercisable for up to 168,972 shares of Series B Convertible Preferred Stock.
- Reduced Exercise Price: $35.72 per share of Series B Convertible Preferred Stock (down from original terms).
- New Warrants Issued: Common stock purchase warrants for up to 200% of the shares issuable upon conversion of the Preferred Stock.
- New Warrant Exercise Price: $0.1482 per share of Common Stock.
- Financial Advisory Fees: 8% of aggregate gross proceeds plus up to $10,000 for legal expenses.
- Use of Proceeds: Working capital, general corporate purposes, and payment of existing indebtedness.
Material Changes and Transaction Mechanics
The filing details a material definitive agreement where the Company reduced the exercise price of existing warrants to induce holders to exercise them. In exchange, holders receive new common stock purchase warrants with a low exercise price ($0.1482) and significant upside potential (200% of converted shares). The transaction is subject to stockholder approval, which must be sought within 90 days of the agreement date. The Company has agreed to a 30-day lock-up on issuing new common stock or equivalents, subject to exceptions.
Guidance, Risks, and Contingencies
- Uncertainty of Proceeds: There is no guarantee that all existing warrants will be exercised; the $6.0 million figure is a maximum potential amount.
- Stockholder Approval: The issuance of New Warrants is contingent upon stockholder approval at a meeting to be held within 90 days.
- Registration Requirements: The Company must file a resale registration statement within 45 days of stockholder approval and keep it effective.
- Anti-Dilution and Call Provisions: New Warrants include anti-dilution protection and a "Call" feature allowing the Company to cancel unexercised warrants for $0.0001 per share if specific trading volume and price thresholds are met.
- Ownership Limitations: Beneficial ownership limitations of 4.99% or 9.99% apply to the exercise of New Warrants.
Investor Verification Checklist
- Verify the actual number of Existing Warrants exercised to determine actual capital raised versus the $6.0 million maximum.
- Confirm the date and outcome of the stockholder meeting required to approve the New Warrants.
- Review the impact of the 200% warrant issuance on existing shareholder dilution.
- Monitor the Company's ability to file and maintain the effectiveness of the Resale Registration Statement.
- Check for any subsequent equity issuances that might trigger anti-dilution adjustments to the New Warrant exercise price.